More Cogstate Ltd news
Cogstate LtdASX: CGS

Interim Business Update

Dec 5, 2017 at 3:36 AM EST · Issued by Cogstate Ltd

Filed with ASX · Dec 5, 2017 at 3:36 AM EST · 1 page · English

On 6ix: 6ix.com/news/interim-business-update

Watch Cogstate's latest callCogstate (ASX:CGS) Q4 2026 Earnings Call · Replay · Aug 17↗

Cogstate Ltd on 6ix

Story so far

  • Business Update - Unaudited Full Year Profit ResultsMar 30, 2016
  • Business Update and First Half Financial GuidanceMar 30, 2016
  • 30 Sep 2013 Business Update and Appendix 4CMar 30, 2016

Earlier from Cogstate

  • Cogstate cleared by FDA to start marketing Cognigram in U.S.Jul 26, 2017
  • FY17 Earnings UpdateJul 10, 2017
  • Cogstate selected as preferred provider for LillyMay 17, 2017
  • Appendix 4D and Half-Year Financial ReportFeb 22, 2017
  • Cogstate enters into agreement with Clinical InkOct 25, 2016

Later from Cogstate

  • Global Alzheimer Platform Foundation Selects CogstateJan 24, 2018
  • Appendix 4D & Half Year Financial ReportFeb 20, 2018
  • S&P DJ Indices Announces March Quarterly RebalanceMar 8, 2018
  • Cogstate Establishes Rare Disease and Pediatric ExpertiseApr 5, 2018
  • Business Update & Appendix 4CApr 12, 2018
All Cogstate news releases↗

Follow Cogstate into a list and get an email when it puts out news.

Follow Cogstate
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer